Achyut Healthcare Share Price
Sector: Biotechnology & Drugs
3.65 +0.11 (3.11%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
3.38
Today’s High
3.65
52 Week Low
2.82
52 Week High
6.25
Key Metrics
- Market Cap (In Cr) 85.98
- Beta -
- Div. Yield (%) 0
- P/B 2.75
- TTM P/E 130.56
- Sector P/E 22.28
- D/E 0
- Open Price 3.53
- Prev Close 3.54
Achyut Healthcare Analysis
Price Analysis
-
1 Week10.27%
-
3 Months11.96%
-
6 Month1.39%
-
YTD-7.83%
-
1 Year4.01%
Risk Meter
- 53% Low risk
- 53% Moderate risk
- 53% Balanced Risk
- 53% High risk
- 53% Extreme risk
Achyut Healthcare News
Q2 Results Today: HDFC Bank, RBL Bank, 20 others to declare Q2 results 2024
1 min read . 19 Oct 2024Stock below ₹50 declares 1:2 bonus issue, scrip up 175% in 6 months
2 min read . 19 Mar 2023Achyut Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 3.05
- Selling/ General/ Admin Expenses Total
- 0.14
- Depreciation/ Amortization
- 0.02
- Other Operating Expenses Total
- 0.24
- Total Operating Expense
- 3.27
- Operating Income
- -0.22
- Net Income Before Taxes
- 0.7
- Net Income
- 0.55
- Diluted Normalized EPS
- 0.02
- Period
- 2025
- Total Assets
- 32.59
- Total Liabilities
- 1.29
- Total Equity
- 31.3
- Tangible Book Valueper Share Common Eq
- 1.33
- Period
- 2025
- Cashfrom Operating Activities
- -4.06
- Cashfrom Investing Activities
- 4.69
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.62
- Period
- 2024
- Total Revenue
- 6.14
- Selling/ General/ Admin Expenses Total
- 0.11
- Depreciation/ Amortization
- 0.01
- Other Operating Expenses Total
- 0.47
- Total Operating Expense
- 6.12
- Operating Income
- 0.02
- Net Income Before Taxes
- 0.74
- Net Income
- 0.57
- Diluted Normalized EPS
- 0.02
- Period
- 2024
- Total Assets
- 30.95
- Total Liabilities
- 0.2
- Total Equity
- 30.75
- Tangible Book Valueper Share Common Eq
- 1.31
- Period
- 2024
- Cashfrom Operating Activities
- -0.36
- Cashfrom Investing Activities
- -15.23
- Cashfrom Financing Activities
- 15.72
- Net Changein Cash
- 0.14
- Period
- 2023
- Total Revenue
- 2.7
- Selling/ General/ Admin Expenses Total
- 0.07
- Depreciation/ Amortization
- 0.01
- Other Operating Expenses Total
- 0.94
- Total Operating Expense
- 2.98
- Operating Income
- -0.28
- Net Income Before Taxes
- 0.31
- Net Income
- 0.23
- Diluted Normalized EPS
- 0.01
- Period
- 2023
- Total Assets
- 15.34
- Total Liabilities
- 0.82
- Total Equity
- 14.52
- Tangible Book Valueper Share Common Eq
- 0.74
- Period
- 2023
- Cashfrom Operating Activities
- -0.43
- Cashfrom Investing Activities
- -4.81
- Cashfrom Financing Activities
- 5.21
- Net Changein Cash
- -0.03
- Period
- 2022
- Total Revenue
- 4.05
- Selling/ General/ Admin Expenses Total
- 0.03
- Depreciation/ Amortization
- 0.01
- Other Operating Expenses Total
- 0.74
- Total Operating Expense
- 4.09
- Operating Income
- -0.04
- Net Income Before Taxes
- 0.1
- Net Income
- 0.04
- Diluted Normalized EPS
- 0
- Period
- 2022
- Total Assets
- 9.94
- Total Liabilities
- 0.86
- Total Equity
- 9.08
- Tangible Book Valueper Share Common Eq
- 0.64
- Period
- 2022
- Cashfrom Operating Activities
- -6.82
- Cashfrom Investing Activities
- -1.73
- Cashfrom Financing Activities
- 8.79
- Net Changein Cash
- 0.24
- Period
- 2021
- Total Revenue
- 0.27
- Other Operating Expenses Total
- 0.03
- Total Operating Expense
- 0.26
- Operating Income
- 0.01
- Net Income Before Taxes
- 0.01
- Net Income
- 0.01
- Diluted Normalized EPS
- 0
- Period
- 2021
- Total Assets
- 0.5
- Total Liabilities
- 0.25
- Total Equity
- 0.25
- Tangible Book Valueper Share Common Eq
- 0.02
- Period
- 2021
- Period
- 2025-03-31
- Total Revenue
- 0.92
- Selling/ General/ Admin Expenses Total
- 0.08
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.17
- Total Operating Expense
- 1.05
- Operating Income
- -0.13
- Net Income Before Taxes
- 0.23
- Net Income
- 0.19
- Diluted Normalized EPS
- 0.01
- Period
- 2025-03-31
- Total Assets
- 32.59
- Total Liabilities
- 1.29
- Total Equity
- 31.3
- Tangible Book Valueper Share Common Eq
- 1.33
- Period
- 2025-03-31
- Cashfrom Operating Activities
- -4.06
- Cashfrom Investing Activities
- 4.69
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.62
- Period
- 2024-09-30
- Total Revenue
- 2.13
- Selling/ General/ Admin Expenses Total
- 0.06
- Depreciation/ Amortization
- 0.01
- Other Operating Expenses Total
- 0.07
- Total Operating Expense
- 2.21
- Operating Income
- -0.09
- Net Income Before Taxes
- 0.47
- Net Income
- 0.35
- Diluted Normalized EPS
- 0.01
- Period
- 2024-09-30
- Total Assets
- 31.93
- Total Liabilities
- 0.83
- Total Equity
- 31.1
- Tangible Book Valueper Share Common Eq
- 1.32
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -2.07
- Cashfrom Investing Activities
- 2.53
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.46
- Period
- 2024-03-31
- Total Revenue
- 4.65
- Selling/ General/ Admin Expenses Total
- 0.06
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.18
- Total Operating Expense
- 4.67
- Operating Income
- -0.01
- Net Income Before Taxes
- 0.4
- Net Income
- 0.23
- Diluted Normalized EPS
- 0.01
- Period
- 2024-03-31
- Total Assets
- 30.95
- Total Liabilities
- 0.2
- Total Equity
- 30.75
- Tangible Book Valueper Share Common Eq
- 1.31
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -0.36
- Cashfrom Investing Activities
- -15.23
- Cashfrom Financing Activities
- 15.72
- Net Changein Cash
- 0.14
- Period
- 2023-09-30
- Total Revenue
- 1.48
- Selling/ General/ Admin Expenses Total
- 0.05
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.29
- Total Operating Expense
- 1.45
- Operating Income
- 0.03
- Net Income Before Taxes
- 0.35
- Net Income
- 0.35
- Diluted Normalized EPS
- 0.02
- Period
- 2023-09-30
- Total Assets
- 15.13
- Total Liabilities
- 0.35
- Total Equity
- 14.78
- Tangible Book Valueper Share Common Eq
- 0.75
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 0.11
- Cashfrom Investing Activities
- -0.22
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.1
- Period
- 2023-03-31
- Total Revenue
- 0.81
- Selling/ General/ Admin Expenses Total
- 0.03
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.51
- Total Operating Expense
- 1.1
- Operating Income
- -0.29
- Net Income Before Taxes
- 0.07
- Net Income
- -0.01
- Diluted Normalized EPS
- 0
- Period
- 2023-03-31
- Total Assets
- 15.34
- Total Liabilities
- 0.82
- Total Equity
- 14.52
- Tangible Book Valueper Share Common Eq
- 0.74
- Period
- 2023-03-31
- Cashfrom Operating Activities
- -0.43
- Cashfrom Investing Activities
- -4.81
- Cashfrom Financing Activities
- 5.21
- Net Changein Cash
- -0.03
- Period
- 2022-09-30
- Total Revenue
- 1.89
- Selling/ General/ Admin Expenses Total
- 0.04
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.44
- Total Operating Expense
- 1.88
- Operating Income
- 0.01
- Net Income Before Taxes
- 0.24
- Net Income
- 0.24
- Diluted Normalized EPS
- 0.02
- Period
- 2022-09-30
- Total Assets
- 10.81
- Total Liabilities
- 1.49
- Total Equity
- 9.32
- Tangible Book Valueper Share Common Eq
- 0.66
- Period
- 2022-09-30
- Cashfrom Operating Activities
- 0.36
- Cashfrom Investing Activities
- 0.4
- Net Changein Cash
- 0.77
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Achyut Healthcare Technical
Moving Average
SMA
- 5 Day3.48
- 10 Day3.48
- 20 Day3.51
- 50 Day3.45
- 100 Day3.61
- 300 Day4.03
Achyut Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Mercury Laboratories
- 856
- -4.85
- -0.56
- 1190
- 736
- 104.03
- Source Natural Foods & Herb Supl
- 158.75
- -4.65
- -2.85
- 269.75
- 105.2
- 103.55
- Achyut Healthcare
- 3.65
- 0.11
- 3.11
- 6.25
- 2.82
- 85.98
- Sunil Healthcare
- 83
- 3.99
- 5.05
- 104
- 60.55
- 85.12
- Remedium Lifecare
- 0.95
- 0.04
- 4.4
- 15.13
- 0.8
- 83.79
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Mercury Laboratories
- 32.66
- 1.92
- 10.75
- 6.6
- Source Natural Foods & Herb Supl
- 35.2
- 4.57
- 15.33
- 9.08
- Achyut Healthcare
- 182.5
- 2.75
- -
- -
- Sunil Healthcare
- -
- 1.27
- 3.38
- 1.88
- Remedium Lifecare
- 27.22
- 1.25
- -
- -
Achyut Healthcare Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 29-May-25
- Audited Results
- 17-Apr-25
- Others
- 19-Oct-24
- Half Yearly Results, Bonus & Stock Split
- 28-May-24
- Audited Results
- 15-Nov-23
- Preferential issue of shares
- 04-Nov-23
- Half Yearly Results
- 27-May-23
- Audited Results
- 05-Jan-23
- Preferential issue of shares
- 21-Nov-22
- Preferential issue of shares
- 12-Nov-22
- Half Yearly Results
- Meeting Date
- Announced on
- Purpose
- 26-May-25
- 23-Apr-25
- POM
- 19-Nov-24
- 23-Oct-24
- EGM
- 30-Sept-24
- 10-Sept-24
- AGM
- 15-Dec-23
- 23-Nov-23
- EGM
- 23-Sept-23
- 28-Aug-23
- AGM
- 17-Apr-23
- 21-Mar-23
- EGM

- Announced on
- Record Date
- Ex-Bonus
- Description
- 19-Oct-24
- 10-Dec-24
- 10-Dec-24
- Bonus issue in the ratio of 4:10 of Re. 1/-.
- 18-Mar-23
- 25-Apr-23
- 25-Apr-23
- Bonus issue in the ratio of 1:2 of Rs. 10/-.
- Ex-Splits
- Old FV
- New FV
- Description
- 10-Dec-24
- 10
- 1
- Stock split from Rs. 10/- to Re. 1/-.
